Marvell Stock Has More Than Tripled This Year. I Think It Can Double Again by 2031.

Marvell reported fiscal Q2 2027 revenue growth of 37% year over year to $2.74 billion, while adjusted EPS rose 40% to $0.94 and adjusted operating margin expanded 180bps to 36.6%. Management guided for roughly $3.15 billion in current-quarter revenue, implying more than 50% growth, and expects fiscal 2028 revenue of about $18 billion as custom AI-chip revenue more than doubles. The bullish thesis targets a potential doubling of the stock to about $527 by 2031, requiring approximately 15% annual earnings growth after fiscal 2028, though lower custom-chip margins, a potential AI-spending slowdown, and substantial share-price volatility remain key risks.

Analysis

MRVL’s key underwriting issue is not top-line AI exposure but conversion of custom-silicon volume into durable per-share earnings. The Google warrant effectively functions as a contingent customer-acquisition cost: each incremental purchase tranche may create economic dilution, so headline custom revenue can overstate value creation unless gross margin, warrant accounting, and share-count guidance improve together. A shift toward custom ASICs also lowers unit economics versus proprietary networking and storage products, making the 38%-40% operating-margin range the critical proof point rather than revenue beats alone.

Competitive risk is asymmetric over the next 1-3 months. AVGO remains the market’s cleaner custom-AI benchmark with deeper customer relationships and greater scale, while NVDA’s platform roadmap can pressure the addressable market for merchant interconnect and custom architectures if customers prioritize tightly integrated GPU systems. Conversely, sustained custom-chip deployment expands demand for high-speed optical connectivity, benefiting MRVL but also optical-component suppliers such as COHR and LITE; supply tightness in advanced optical modules could constrain MRVL’s revenue conversion despite strong end demand.

The consensus appears to extrapolate current growth while assuming valuation durability. At an elevated earnings multiple after a sharp rerating, even execution consistent with long-term targets could produce a flat-to-down stock if the market shifts from AI-capex scarcity to return-on-invested-capital scrutiny. The near-term catalyst is whether long-range targets explicitly bridge custom revenue to gross margin, dilution, and FCF; falsification would be a margin guide below the stated range, incremental warrant dilution without corresponding backlog visibility, or hyperscaler AI-capex moderation in the next two reporting cycles.

Key Decisions for Investors

• Do not chase MRVL outright ahead of the investor-day catalyst; initiate only on a post-event pullback if management provides explicit fiscal-2029/2030 gross-margin and diluted-share-count targets. Underwrite a 15%-20% drawdown risk versus a 25%-35% upside over 6-12 months if margin expansion and customer concentration concerns are addressed.
• Express a quality pair over 3-6 months: long AVGO / short MRVL in equal AI-semiconductor beta. AVGO offers more diversified custom-silicon economics; the pair should work if investors begin discounting MRVL’s lower-margin mix or Google-related dilution. Exit if MRVL demonstrates custom gross margins and FCF conversion materially above expectations for two consecutive quarters.
• For a tactical bullish position, use a defined-risk MRVL call spread dated 3-6 months beyond the investor-day and next earnings release rather than common stock. The trade requires confirmation that the long-term revenue outlook is accompanied by EPS and share-count guidance; otherwise implied volatility and elevated expectations leave poor upside asymmetry.
• Monitor COHR and LITE as second-order beneficiaries of accelerating 1.6T optical deployments. Prefer a basket only if lead times or capacity commentary tighten; absent independent evidence of component shortages, treat these as watch-list exposures rather than direct read-through trades.